Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bombesin antagonists

Bombesin antagonists

US Patent 5620959 · Granted Apr 15, 1997

Estimated economic value: $16,924,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase i2021
Method of inhibiting DYRK1B2020
Heterocyclic compounds with working memory enhancing activity2019
2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors2018
Method of inhibiting DYRK1B2018
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of can2017
Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proli2014
IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation2013
Anti-inflammatory agents as virostatic compounds2013
IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation2013
Heterocyclic NF-κB inhibitors2012
Heterocyclic NF-κB inhibitors2010